Table 1.
Patients characteristics and prescribed dose.
| Characteristic | Patients |
||
|---|---|---|---|
| No | % | ||
| Sex | Male | 28 | 64 |
| Female | 16 | 36 | |
| Age, years | Mean | 67 | |
| Range | 39–85 | ||
| Cancer site | Oral | 10 | 23 |
| Oropharynx | 12 | 27 | |
| Hypopharynx/Larynx | 9 | 20 | |
| Epipharynx | 1 | 2 | |
| Parotic gland | 7 | 16 | |
| Outer ear canal/Skin | 3 | 7 | |
| Unknown primary head and neck | 2 | 5 | |
| Prescribed dose to primary tumour | 68 (2 Gy/fx) Gy | 3 | 7 |
| 54 (3 Gy/fx) Gy | 2 | 5 | |
| 46 (2 Gy/fx) Gy | 1 | 2 | |
| Prescribed dose to primary tumour and lymph nodes | 68 Gy + 68 (2 Gy/fx) | 11 | 25 |
| 68 Gy + 52.7 (1.55 Gy/fx) Gy | 27 | 61 | |